Continue
By using our website you accept our cookies policy.Find out more

Aligning international efforts in the fight against antimicrobial resistance

Posted on 04/05/2018

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) has recently announced two new calls for transnational networks.

The increasing threat to public health from antimicrobial resistance (AMR) is causing world-wide concern, by impairing our ability to effectively prevent and treat an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) was initially formed by 15 European Countries with the support of the European Commission and has evolved to comprise 26 countries globally. It funds basic and exploratory research on new antibiotics, stewardship of existing antibiotics, and studies and control of the spread of antibiotic resistance between humans, animals, and the environment in a One Health perspective.

JPIAMR has recently announced  two new calls for transnational networks:

Working to Improve Surveillance

Surveillance networks are essential to monitor the threat of AMR and guide public health policy. The JPIAMR call for networks aims to create networks to enhance resource alignment and efforts in the field of AMR surveillance.

In partnership with ten member countries; Belgium, France, Germany, Ireland, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom, JPIAMR is launching the seventh joint call for transnational networks. The total budget of the call is approximately €1.1 million.

This network call “Working to Improve Surveillance” aims to create networks to enhance resource alignment and efforts in the field of AMR surveillance. Surveillance is a prerequisite for assessing the success of AMR stewardship measures, infection prevention and control, and the effectiveness of new therapeutic and diagnostic options. The overarching goal of JPIAMR research on surveillance is to standardise, improve and extend surveillance systems on antibiotic use and on AMR in humans, animals, food, and the larger environment.

In this network call up to 21 networks will be funded with up to €50,000 each to maximise existing and future efforts to combat AMR by pushing forward new ideas in AMR surveillance. Note that JPIAMR networks calls do not fund research projects.

The proposal submission deadline is June 12th, 2018, (14.00h CET).

You can find out more here.

Building the Foundation of the JPIAMR Virtual Research Institute

JPIAMR recognises a need to reinforce alignment of AMR research. To promote this, the JPIAMR will establish a Virtual Research Institute in AMR – a global network connecting research performing organisations, including institutes, centres, and infrastructures.

In partnership with ten member countries; Canada, Egypt, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom, JPIAMR is launching the eight joint call for transnational networks. The total budget of the call is approximately €1.1 million.

The network call “Building the Foundation of the JPIAMR Virtual Research Institute” aims to identify research community needs and develop ideas to form the foundation for the JPIAMR-VRI. Networks of motivated groups should develop catalytic ideas and strategic plans to help bring the JPIAMR-VRI to life!

Up to 22 Networks will be funded with up to €50,000, each coordinator to connect experts from research performing organisations and establish expertise clusters in the AMR community. The formation of larger, multi-coordinator Networks is possible according to national rules. This is an ERA-NET JPI-EC-AMR additional activity.

Note that JPIAMR Network calls do not fund research projects.

The proposal submission deadline is July 4th, 2018, (17.00 CET).

You can find out more here.

Related Content

Innovate UK competition for UK-China collaboration to tackle AMR now open
Innovate UK has opened a collaborative competition to work with Chinese partners to tackle the growing threat of antimicrobial resistance. 
Formulation challenges for traditional and next generation biopharmaceuticals
The next Biopharmaceutical Formulation Group meeting is being held on 5th July 2018 at the Manchester Institute of Biotechnology.
Improving the prevention, treatment and cure of infectious diseases
KTN invites expressions of interest for an EU partnering event on infectious diseases, taking place on 22nd May in London.